ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Sorrento Therapeutics Inc (CE)

Sorrento Therapeutics Inc (CE) (SRNE)

0.0006
-0.0002
(-25.00%)
마감 04 1월 6:00AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
0.0006
매수가
0.00
매도가
0.00
거래량
44,530
0.0002 일간 변동폭 0.0006
0.0001 52주 범위 0.0925
전일 종가
0.0008
개장가
0.0002
최근 거래 시간
18000
@
0.0006
마지막 거래 시간
평균 볼륨(3m)
361,862
재정 규모
US$ 25
VWAP
0.00057

SRNE 최신 뉴스

Sorrento Therapeutics Announces Full Exercise of Over-Allotment Option

Sorrento Therapeutics Announces Full Exercise of Over-Allotment Option PR Newswire SAN DIEGO, Oct. 25, 2013 SAN DIEGO, Oct. 25, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE...

Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain

Sorrento Therapeutics Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain PR Newswire SAN DIEGO, Oct. 10, 2013 SAN DIEGO, Oct. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics...

Sorrento Therapeutics Announces a Presentation on Cynviloq™ at the AACR Conference on Advances in Ovarian Cancer Research: ...

Sorrento Therapeutics Announces a Presentation on Cynviloq™ at the AACR Conference on Advances in Ovarian Cancer Research: From Concept to Clinic PR Newswire SAN DIEGO, Sept. 16, 2013 SAN DIEGO...

Sorrento Therapeutics Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personaliz...

Sorrento Therapeutics Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy PR Newswire SAN DIEGO, Sept. 10, 2013 SAN...

Sorrento Therapeutics Completes IgDraSol Merger

Sorrento Therapeutics Completes IgDraSol Merger PR Newswire SAN DIEGO, Sept. 10, 2013 SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC QB: SRNE; Sorrento) announced...

Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq™ under 505(b)(2) Bioequivalence Regulatory Pathway

Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq™ under 505(b)(2) Bioequivalence Regulatory Pathway Official Minutes from End-of-Phase 2 FDA Meeting Provide Clarity on Next...

Sorrento Therapeutics Announces Reverse Split of Common Stock

Sorrento Therapeutics Announces Reverse Split of Common Stock PR Newswire SAN DIEGO, Aug. 1, 2013 SAN DIEGO, Aug. 1, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento...

Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th Internation...

Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th International Nanomedicine Conference in Sydney, Australia PR Newswire SAN DIEGO...

Sorrento Therapeutics Receives Frost & Sullivan's Prestigious 2013 Global Investment Opportunity Award in the Oncology Market

Sorrento Therapeutics Receives Frost & Sullivan's Prestigious 2013 Global Investment Opportunity Award in the Oncology Market PR Newswire MOUNTAIN VIEW, California, June 6, 2013 MOUNTAIN...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1000.00060.000950.00029559670.00056067CS
40.0001200.00050.010.00015967260.00094844CS
12-0.0034-850.0040.0140.00013618620.00197128CS
26-0.0094-940.010.09250.00012379830.0036731CS
52-0.0154-96.250.0160.09250.00012095230.00665423CS
156-7.8594-99.99236641227.867.860.00012039210.00665423CS
260-7.8594-99.99236641227.867.860.00011975810.00665423CS

SRNE - Frequently Asked Questions (FAQ)

What is the current Sorrento Therapeutics (CE) share price?
The current share price of Sorrento Therapeutics (CE) is US$ 0.0006
What is the 1 year trading range for Sorrento Therapeutics (CE) share price?
Sorrento Therapeutics (CE) has traded in the range of US$ 0.0001 to US$ 0.0925 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EGIOQEdgio Inc (CE)
US$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
US$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
US$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
US$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
US$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
US$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
US$ 0.00125
(-10.71%)
169.44M
northam43 northam43 2 분 전
Report #1 Status Report.

https://investorshub.advfn.com/uimage/uploads/2025/1/3/xyvnn1_Status_Report.PNG
scottyb scottyb 3 분 전
you tell us
VRSSF
Toronto_Trader Toronto_Trader 3 분 전
This of from real life experience of 8 years. You will not find any Canadian securities trading below $0.005. In fact, all bids and asks are executed on 1/2 cent increments up until $0.50 (if I recall) and then from $0.01 increments thereafter.

I trade US securities though the same b
TWOH
CommonCents3 CommonCents3 4 분 전
Agreed. Due to the fact that there are basically zero side effects, there is no reason to not approve it. It's for this same reason that I believe we won't be asked to perform another trial prior to approval. Drugs with dangerous side effects must be tested and tested to prove that the potential ben
AVXL
DonVance DonVance 5 분 전
Elon is going to be a trillionaire soon.
TSLA
StockInfo11 StockInfo11 5 분 전
NEXG.v CEO, Morgan Lekstrom, recently highlighted growth plans after acquiring Signal Gold.
https://youtu.be/_Ja1A276T4M
NEXG’s Goliath & Goldboro projects hold 6 Moz in resources, targeting 200,000 oz/year gold production. Permitting is nearing completion, with construction decisions
NXGCF
BullNBear52 BullNBear52 5 분 전
So Hindenburg is not saying anything new and just chose to throw gasoline on the fire. Which had nothing to do with their audit firm. VC money isn't easy to come by.

Sorry but as I said in the past if Hindenburg wants to prove themselves as legit why don't they dig into Tesla? Or do
TSLA
Hosai Hosai 6 분 전
Doc why do you keep saying MMSE status refers merely to being above or below 20.

As you have stated youself, the eligiblity criteria was only for people with MMSE scores between 20 and 28 being in the study. Why would they have pre-specified for the only MMSE co-variate adjustment to
AVXL
Monroe1 Monroe1 6 분 전
Jordan Peterson is right on.
mkt_predictor mkt_predictor 6 분 전
I saw, good stuff. Sounds like a lot more information will be released over the coming weeks. Should help this sustain a nice move over that period and then some. First area to break/hold is .0012, then .002 area. If it can get there, and I don't see why it can't/won't especially with this share
HADV
Shawonsarker84 Shawonsarker84 7 분 전
Almost 400M buy today out of 545M total. HMBL will rise and shine again!!


Buy: 396M

Neutral: 67M

Sell: 82M


HMBL
Mr Georgi Mr Georgi 7 분 전
And it's going to be sooner than later BIG news will be announced I have been buying for a month steady 
PWDY
stoxjock stoxjock 8 분 전
That's true....I hope they will Re-instate CTs ASAP....I was hoping to parlay some of the CTs recoveries to buy more FnF, was hoping FnF wouldn't run away from me.... But that Ackman guy riled up a lot of noise on FnF and caused a Price spike last Friday for his EOY 'Dressing'....I hope they will pu
LEHNQ
meds4life meds4life 8 분 전
Many of these slides they'll be putting up are too complex, cluttered with data, impossible to grok in the 15 seconds or so it'll be projected. Just like winning candidates' KEEP IT SIMPLE ...with one main point to get across per slide.
AVXL
StockInfo11 StockInfo11 8 분 전
Protium Clean Energy (GRUV.c) targets the fast-growing white hydrogen market, projected to reach $9.34B by 2032. Using satellite imaging and AI-based data analysis GRUV has identified key hydrogen anomalies in Ontario, positioning it to support the clean energy transition. Full DD here⬇️
http
GRUV
along4zride along4zride 9 분 전
I wonder if Acknam has the $187 Billion that has been owned to USG for the last 17 (FNMA) years .
There will be no privatizing until that balance is paid.
FNMA
rosemountbomber rosemountbomber 9 분 전
A few people have mentioned Denner/Sarissa having a short position here, but I haven't seen anything corroborating or confirming that 
AMRN
pos_stock_hoarder pos_stock_hoarder 10 분 전
That, alone, would be wonderful!
blackcat blackcat 10 분 전
George having good ideas.
https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:4lx6nur5wstwoc4wtgj56kyu/bafkreic25yokfgmwihztfuvqu74szcbqv6ecv3mhswhaxywhcgykupow4q@jpeg
Monroe1 Monroe1 10 분 전
Never add a ton when a pharma or any stock is in an early stage. And do I have proof for the Pigs at Pig Pharma. How about over 40 years of pharma research?? I have all the proof I need and if that is not enough.... where have you been during this covid scam? That alone should raise some eyebrows an
BIXT
boi568 boi568 10 분 전
I think it's confidential at this stage, but the EMA will see it.
AVXL
Investor082 Investor082 11 분 전
How will they run any of those trials without cash? Don’t forget pediatric trial for UK, which they need to get done before 2027/2028.

None of those trials will get off the ground except some paperwork BS. The “fast trial” carrot has already been dangled by the social media crew since
NWBO

최근 히스토리

Delayed Upgrade Clock